Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease Genetics
Study results from University of California, Department of Neurology provide new insights into Alzheimer disease genetics
May 18th, 2008
Investigators publish new data in the report 'Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease.' "We developed and validated a new method to create automated 3D parametric surface models of the lateral ventricles in brain MRI scans, providing an efficient approach to monitor degenerative disease in clinical studies and drug trials. First, we used a set of parameterized surfaces to represent the ventricles in four subjects' manually labeled brain MRI scans (atlases)," scientists in the United States report. "We fluidly registered each atlas and mesh model to MRIs from 17 Alzheimer's disease (AD) patients...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-18)
|
